Indianapolis Biotech Marks Growing Milestone in the Fight Against Blood CancerINDIANAPOLIS--(BUSINESS WIRE)--This week, Ossium Health hosted a facility tour and reception at its Indianapolis ...

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

Rich Market with Strategically Aligned CustomersROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” ...

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain ...

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / Queue Ventures Ltd. ("Queue" or the "Company") is ...

"A federal pilot built on the 0.3% THC loophole is reshaping cannabinoid access policy-without FDA approval, without ...

BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws.NEW YORK--(BUSINESS WIRE)--$ADMA ...

Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

Neuro-symbolic, multi-agent AI system achieves 4x faster trial matching with oncologist-confirmed accuracy across 17,000+ ...

NR is the first among NR, NMN, and NAD+ to receive a pharmacopeial quality benchmark, reinforcing Niagen Bioscience’s leadership in NAD+ science and ingredient qualityLOS ANGELES--(BUSINESS ...

Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions ...

Behavior Labs launches a decision intelligence platform that gives pharma, biotech, and medical device teams continuous competitive and market intelligence and scenario modelling — replacing quarterly ...